Actuate Therapeutics, Inc. Deferred Costs, Noncurrent
Actuate Therapeutics, Inc. (ACTU) had Deferred Costs, Noncurrent of $1.18 million as of 2024-06-30, per its 10-Q filed 2024-09-24.
Discontinued › Balance Sheet
us-gaap:DeferredCosts · last filed 2024-09-24
- 2024-06-30: Deferred Costs, Noncurrent $1.18M.
- 2023-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2024-06-30 | $1.18M 10-Q · filed 2024-09-24 |
| 2023-12-31 | $0.00 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |